NCT00698126View on ClinicalTrials.gov

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

4,099

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

soluble human insulin

Observational study; use of the products as in the normal clinical practice conditions

DRUG

biphasic insulin aspart

Observational study; use of the products as in the normal clinical practice conditions

Trial Locations (1)

00144

Novo Nordisk Investigational Site, Rome

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY